Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Funding available for cancer centers to support research in basic laboratory, clinical, prevention, control, and population-based research, with a focus on collaboration and integration across disciplines.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: February 23, 2026 (current full application deadline) | September 25, 2021 (previous full application deadline)
Funding Amounts: New applications: up to $1.2M–$1.4M direct costs/year (5-year period); renewals: no stated limit, based on project needs.
Summary: Supports NCI-designated Cancer Centers in advancing transdisciplinary cancer research, infrastructure, and community engagement.
Key Information: Only one application per institution; $10M annual cancer-focused funding base required for new applicants.
Description
This opportunity supports P30 Cancer Center Support Grants (CCSGs) to enhance the capabilities and impact of NCI-designated Cancer Centers. The program is designed to foster transdisciplinary cancer research, facilitate the development of shared research resources, and promote collaborative efforts across laboratory, clinical, and population-based research areas. Centers are expected to serve as hubs of discovery, innovation, and community engagement, translating research findings into improved cancer prevention, diagnosis, and therapy. The grant mechanism is open to both new and renewal applicants, with clinical trial activities being optional.
